The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: revlimid     Quarter: 2016Q3

Total Drug/Injury Combinations: 1,509     Number of Pages: 76

DRUGNAME PT EventCount
REVLIMID Vascular insufficiency 1 view events
REVLIMID Vertigo CNS origin 1 view events
REVLIMID Vitamin D abnormal 1 view events
REVLIMID Vitamin D increased 1 view events
REVLIMID Vocal cord paralysis 1 view events
REVLIMID Waldenstrom's macroglobulinaemia 1 view events
REVLIMID Wheezing 1 view events
REVLIMID White blood cell analysis abnormal 1 view events
REVLIMID Wound evisceration 1 view events

Total Drug/Injury Combinations: 1,509     Number of Pages: 76

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)